Tilray expands medical cannabis portfolio in germany

NeumÜnster, germany, feb. 11, 2025 (globe newswire) -- tilray medical (“tilray”), a division of tilray brands, inc. (nasdaq: tlry and tsx: tlry), and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the expansion of its industry-leading medical cannabis extract portfolio in germany. tilray's new medical cannabis offerings in germany includes the introduction of an additional product size for its top-selling medical cannabis extract, along with a new formulation aimed at addressing the diverse needs of patients and healthcare providers.
TLRY Ratings Summary
TLRY Quant Ranking